METTL3 and metabolic dysfunction-associated steatotic liver disease: METTL3 plays a dual role in NAFLD pathogenesis: (1) Promotes disease progression via MYC mRNA modification mechanisms [127]; (2) Exerts protective effects against non-alcoholic steatohepatitis by suppressing CCL2-mediated inflammation and CD36-dependent hepatic FFA uptake [128].